Liraglutide as add-on to Insulin in Type 1 Diabetes
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to:
Part 1:
To investigate how 12 weeks treatment with liraglutide affects glycemic control in poorly
controlled patients and how the treatment affects gastric emptying rate during hypoglycemia.
Part 2:
To investigate how 12 weeks treatment of type 1 diabetic patients with liraglutide affects
counterregulatory hormones and cognitive performance during hypoglycemia.
Phase:
Phase 3
Details
Lead Sponsor:
Hvidovre University Hospital
Collaborators:
Danish PhD schools of Molecular Metabolism and Endocrinology Hillerod Hospital, Denmark NNF Center for Basal Metabolic Research, Denmark Novo Nordisk A/S